Cited by 84Environmental Impact and SustainabilityHealthcare cost, quality, practicesHealthcare and Environmental Waste Management

Quantification of the cost and potential environmental effects of unused pharmaceutical products in cataract surgery

Open access
Tauber, Jenna, Chinwuba, Ijeoma, Kleyn, David, Rothschild, Michael, Kahn, Jonathan, Thiel, Cassandra L.·2019·JAMA Ophthalmology

Abstract

IMPORTANCE: Pharmaceutical products, including unused portions, may contribute to financial and environmental costs in the United States. Because cataract surgery is performed millions of times each year in the United States and throughout the rest of the world, understanding these financial and environmental costs associated with cataract surgery is warranted. OBJECTIVE: To investigate the financial and environmental costs of unused pharmaceutical products after phacoemulsification surgery. DESIGN, SETTING, AND PARTICIPANTS: This descriptive qualitative study included 4 surgical sites in the northeastern United States (a private ambulatory care center, private tertiary care center, private outpatient center, and federally run medical center for veterans). Prices and data for use of services and pharmaceuticals were obtained for the tertiary care and outpatient centers from January 1 through April 30, 2016; for the ambulatory care center from June 1, 2017, through March 31, 2018; and the federal medical center from November 1, 2017, through February 28, 2018. Data were collected from routine phacoemulsification surgical procedures without vitreous loss or other complications. Volume or weight of medications remaining after surgery was measured. Total and mean costs of medications per case and month were calculated. Environmental effects were estimated using economic input-output life cycle assessment methods. Data were analyzed from December 1, 2017, through June 30, 2018. MAIN OUTCOMES AND MEASURES: Cost of unused pharmaceutical products (in US dollars) and kilogram equivalents of carbon emissions (carbon dioxide [CO2-e]), air pollution (fine particulate matter emissions of ≤10 μm in diameter [PM10-e]), and eutrophication potential (nitrogen [N-e]). RESULTS: A total of 116 unique drugs were surveyed among the 4 centers. Assuming unmeasured medications had no materials left unused, a cumulative mean 83 070 of 183 304 mL per month (45.3%) of pharmaceuticals were unused by weight or volume across all sites. Annual unused product cost estimates reached approximately $195 200 per site. A larger percentage of eyedrops (65.7% by volume) were unused compared with injections (24.8%) or systemic medications (59.9%). Monthly unused quantities at the ambulatory care center (65.9% by volume [54 971 of 83 440 mL]), tertiary care center (21.3% [17 143 of 80 344 mL]), federal medical center (38.5% [265 of 689 mL]), and outpatient center (56.8% [10 691 of 18 832 mL]) resulted in unnecessary potential emissions at each center of 2135, 2498, 418, and 711 kg CO2-e/mo, respectively. Unnecessary potential air pollution between sites varied from 0.8 to 4.5 kg PM10-e/mo, and unnecessary eutrophication potential between sites varied from 0.07 to 0.42 kg N-e/mo. CONCLUSIONS AND RELEVANCE: This study suggests that unused pharmaceutical products during phacoemulsification result in relatively high financial and environmental costs. If these findings can be substantiated and shown to be generalizable in the United States or elsewhere, reducing these costs may be of value.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamaophthalmol.2019.2901

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In more developed countries, unused items and partially used items are thrown away with greater frequency.

    “In more developed countries, unused items and partially used items are thrown away with greater frequency.”

    From Improving productivity, costs and environmental impact in International Eye Health Services: using the ‘Eyefficiency’ cataract surgical services auditing tool to assess the value of cataract surgical services (2021) · cites this paper as [25]

    The Discussion (page not provided) reports that partially used antibiotic eyedrop bottles were discarded at four US cataract-surgery sites. The paper does not establish that unused or partially used items are thrown away more frequently in more developed countries than elsewhere; its findings concern pharmaceuticals at US sites. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Single-dose eye drops in preoperative and postoperative settings create substantial physical and financial waste and environmental pollution.

    “Single-dose eye drops in preoperative and postoperative settings have been found to create substantial physical and financial waste and environmental pollution.31”

    From How Ophthalmologists Can Decarbonize Eye Care (2023) · cites this paper as [31]

    The Discussion (page unavailable) reports substantial unused eyedrops and drug costs at four cataract-surgery centers; it also discusses potential environmental effects. But the studied drops were generally 5–15 mL bottles opened for one patient, not packaged single-dose drops. The paper suggests that smaller single-dose containers could reduce unused solution, so its findings do not establish that single-dose drops create the claimed waste and pollution. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 54 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [41]41. Morris JGJ. Harmful algal blooms: an emerging public health problem with possible links to human stress on the environment. Annu Rev Energy Environ. 1999;24(1):367-390. doi:10.1146/annurev.energy.24. 1.367 · DOI

Cited by

Sorted by citations

Authors
Tauber, J., Chinwuba, I., Kleyn, D., Rothschild, M., Kahn, J., & Thiel, C. L.
Affiliations
  • NYU Langone Health (US)
  • City University of New York (US)
Corresponding author
Thiel, Cassandra L.
Venue
JAMA Ophthalmology
Published
2019-10-01
Volume
137
Issue
10
Pages
1156
ISSN
2168-6165 (ISSN-L)
OpenAlex
W2966685989
Cited by
83
References
54
Citations by year
2026: 8 · 2025: 15 · 2024: 7 · 2023: 16 · 2022: 14 · 2021: 12 · 2020: 9 · 2019: 1
FWCI
3.81
Type
journal article
Language
en
Open access
Locations
  • JAMA Ophthalmology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Environmental Science › Environmental Engineering › Environmental Impact and Sustainability
  • Health Sciences › Health Professions › General Health Professions › Healthcare cost, quality, practices
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare and Environmental Waste Management
Keywords
cataract surgery, phacoemulsification, pharmaceutical waste, drug costs, environmental impact of pharmaceuticals, CO2 emissions, PM2.5, eutrophication, life cycle assessment, eye drops, outpatient care, tertiary care hospital

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review